성장을 멈추지 마세요

체험은 만족하셨나요?

현재 45,766명이 마이메르시로 공부 중이에요

지식 자료를 소장하고 멋진 의료인으로 성장하세요

학습 자료 둘러보기 →
Peripherally Acting α-Adrenergic Blockers | 마이메르시 MyMerci
제안하기

뭔가 하고 싶은 말이 있는거야?

0 / 2000
컨텐츠 수정하기

컨텐츠 내용을 수정할 수 있습니다

수정하기
닫기

Peripherally Acting α-Adrenergic Blockers

NCLEX Review Guide: Peripherally Acting α-Adrenergic Blockers

Mechanism of Action & Classification

How α-Adrenergic Blockers Work

  • α-Adrenergic blockers competitively inhibit α-adrenergic receptors, preventing norepinephrine and epinephrine from binding and causing vasoconstriction.
  • These medications promote vasodilation by blocking α1-receptors in vascular smooth muscle, leading to decreased peripheral vascular resistance and blood pressure reduction.
  • Common medications include prazosin (Minipress), terazosin (Hytrin), doxazosin (Cardura), and tamsulosin (Flomax).

Key Points

  • Primary effect: Vasodilation through α1-receptor blockade
  • Reduces both systolic and diastolic blood pressure
  • Also used for benign prostatic hyperplasia (BPH)

Clinical Applications & Therapeutic Uses

Primary Indications

  • Hypertension management - particularly effective as add-on therapy when other antihypertensives are insufficient.
  • Benign Prostatic Hyperplasia (BPH) - α1-blockers relax smooth muscle in the prostate and bladder neck, improving urinary flow.
  • Off-label uses include treatment of Raynaud's phenomenon and certain cases of heart failure.

Clinical Scenario

A 65-year-old male with hypertension and BPH symptoms is prescribed doxazosin. This medication addresses both conditions by reducing blood pressure through vasodilation and improving urinary symptoms by relaxing prostatic smooth muscle.

Critical Nursing Considerations

First-Dose Phenomenon

  • CRITICAL ALERT: First-dose syncope can occur, especially with immediate-release formulations, causing severe hypotension and fainting.
  • Always administer the first dose at bedtime and start with the lowest possible dose to minimize orthostatic hypotension risk.
  • Monitor blood pressure closely for 2-6 hours after initial dose and with each dose increase.

Ongoing Monitoring

  1. Assess blood pressure in supine and standing positions before and after administration
  2. Monitor for signs of orthostatic hypotension (dizziness, lightheadedness, falls)
  3. Evaluate therapeutic response for both hypertension and BPH symptoms
  4. Check for peripheral edema and signs of fluid retention

Key Points

  • First dose at bedtime to prevent syncope
  • Monitor orthostatic vital signs regularly
  • Gradual dose titration prevents adverse effects

Adverse Effects & Safety Concerns

Common Side Effects

  • Orthostatic hypotension - most significant concern, especially in elderly patients or those taking multiple antihypertensives.
  • Dizziness, headache, fatigue, and weakness due to decreased cerebral perfusion from hypotension.
  • Reflex tachycardia may occur as the body compensates for decreased blood pressure.
  • Nasal congestion and peripheral edema are also commonly reported.

Memory Aid: "DIZZY DROPS"

Dizziness
Increased heart rate (reflex)
Zero energy (fatigue)
Zero standing tolerance (orthostatic hypotension)
Yearning for breath (nasal congestion)

Dangerous first dose
Reflex tachycardia
Orthostatic changes
Peripheral edema
Syncope risk

Commonly Confused Concepts

α-Blockers vs β-Blockers

Aspect α-Adrenergic Blockers β-Adrenergic Blockers
Primary Action Block α1-receptors → vasodilation Block β1-receptors → decreased heart rate/contractility
Heart Rate Effect May increase (reflex tachycardia) Decreases heart rate
First-dose Effect Significant syncope risk Minimal first-dose hypotension
BPH Treatment Effective for urinary symptoms No effect on prostate

Key Points

  • α-blockers cause vasodilation; β-blockers reduce cardiac output
  • Only α-blockers treat BPH symptoms
  • α-blockers have higher first-dose syncope risk

Patient Education & Study Tips

Essential Patient Teaching

  • Instruct patients to rise slowly from sitting or lying positions to prevent falls from orthostatic hypotension.
  • Emphasize taking the first dose at bedtime and avoiding driving or operating machinery for 12-24 hours after initial dose.
  • Teach patients to monitor blood pressure at home and report persistent dizziness or fainting episodes.
  • Advise against abrupt discontinuation as rebound hypertension may occur.

NCLEX Memory Strategy: "SLOW START"

Start dose at bedtime
Low dose initially
Orthostatic precautions
Watch for first-dose syncope

Stand up slowly
Titrate gradually
Assess BP regularly
Report dizziness
Take at bedtime

Common NCLEX Pitfalls

  • Don't confuse with β-blockers - α-blockers can cause reflex tachycardia
  • Remember first-dose phenomenon is unique to α-blockers
  • α-blockers treat both hypertension AND BPH (dual benefit)

Quick Knowledge Check

Self-Assessment

  • ☐ I can explain the mechanism of action of α-adrenergic blockers
  • ☐ I understand the first-dose phenomenon and appropriate nursing interventions
  • ☐ I can differentiate between α-blockers and β-blockers
  • ☐ I know the dual indication for hypertension and BPH
  • ☐ I can teach patients about orthostatic precautions
  • ☐ I understand the importance of gradual dose titration

Quick Check Questions

1. What is the most important nursing consideration for the first dose?
2. Why might heart rate increase with α-blockers?
3. What position changes should patients be taught?

You're mastering complex pharmacology concepts! Remember, understanding the "why" behind α-adrenergic blockers' actions will help you answer NCLEX questions confidently. Keep connecting the dots between mechanism, effects, and nursing care - you've got this! 🌟

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.